Article
[The role of SF3B1 mutations in EVI1-rearranged myeloid neoplasms].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2023
Tanaka Atsushi
Abstract excerpt
In acute myeloid leukemia (AML), EVI1 rearrangement represented by inv(3)(q21q26) or t(3;3)(q21;q26) causes EVI1 overexpression via structural rearrangement of an enhancer, and confers poor prognosis. My colleagues and I performed a mutational analysis of EVI1-rearranged myeloid neoplasms and identified SF3B1, a core RNA splicing factor, as the most commonly co-mutated gene. Indeed, latent leukemia development in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
